Abstract
As persons age, their life styles change, and they become more affluent and obese. If this trend continues, the incidence of associated hypertension (HTN) will continue to increase worldwide [1]. At the same time, despite widely recognized dangers of uncontrolled HTN, it is still under-treated in most patients. Such inadequate HTN control is seen not only in closely followed populations, but also in closely monitored anti-HTN drug trials [1]. Moreover, cardiovascular risk remains high in the majority of people with HTN, whether they are treated or not.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Kaplan NM (2005) Systemic hypertension: mechanisms and diagnosis. In: Zipes DP, Libby P, Bonow RO, Braunwald E (eds) Braunwald’s heart disease, 7th edn. Elsevier Saunders, Philadelphia, pp 959–87
Domanski M, Mitchell G. Pferffer F, et al (2002) Pulse pressure and cardiovascular disease-related mortality: follow-up study of the Multiple Risk Factor Intervention Trial (MRFIT). JAMA 287:2677–83
Joint National Committee (1997) The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of high blood pressure. Arch Intern Med 157:2413–46
Joint National Committee (2003) The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The JNC 7 Report. JAMA 289:2560–72
Zainer CM (2007) Herbals and alternative medicine. In: Atlee JL (ed) Complications in anesthesia, 2nd edition. Elsevier Saunders, Philadelphia, pp 150–8
Wong TY, Klein R, Sharrett AR, et al (2002) Retinal arteriolar narrowing and risk of coronary heart disease in men and women: the Atherosclerosis Risk in Communities Study. JAMA 287:1153–9
Schussheim AE, Devere RB, de Simone G (1997) Usefulness of subnormal midwall fractional shortening in predicting left ventricular exercise dysfunction in asymptomatic patients with systemic hypertension. Am J Cardiol 79:1070–4
Aeschbacher BC, Hutter D, Fuhrer H, et al (2001) Diastolic dysfunction precedes myocardial hypertrophy in the development of hypertension. Am J Hypertens 14:106–13
Kozakova M, de Simone G, Morizzo C, Palombo C (2003) Coronary vasodilator capacity and hypertension-induced increase in left ventricular mass. Hypertension 41:224–9
Schmieder RE, Messerli FH (2000) Hypertension and the heart. J Hum Hypertens 14:597–604
Verdecchia P, Schillaci G, Borgioni C, et al (1998) Prognostic significance of serial changes in left ventricular mass in essential hypertension. Circulation 97:48–54
Haider AW, Larson MG, Franklin SS, Levy D (2003) Systolic blood pressure, diastolic blood pressure, and pulse pressure as predictors of risk for congestive heart failure in the Framingham Heart Study. Ann Intern Med 138:10–6
Boon D, Piek JJ, van Montfrans GA (2000) Silent ischaemia and hypertension. J Hypertens 18:1355–64
Haider AW, Chen L, Larson MG, et al (1997) Antecedent hypertension confers increased risk for adverse outcomes after initial myocardial infarction. Hypertension 30:1020–4
Sierra C, de La Sierra A, Mercader J, et al (2002) Silent cerebral white matter lesions in middle-aged essential hypertensive patients. J Hypertens 20:387–9
Goldstein IB, Bartzokis G, Guthrie D, Shapiro D (2002) Ambulatory blood pressure and brain atrophy in the healthy elderly. Neurology 59:713–9
Reinprecht F, Elmstahl S, Janzon L, Andre-Petersson L (2003) Hypertension and changes of cognitive function in 81-year-old men: a 13-year follow-up of the population study “Men born in 1914”, Sweden. J Hypertens 21:57–66
Mansoor GA, Frishman WH (2002) Comprehensive management of hypertensive emergencies and urgencies. Heart Dis 4:358–71
Strandgaard S, Paulsen OB (1989) Cerebral blood flow and its pathophysiology in hypertension. Am J Hypertens 2:486–92
Preston RA, Jy W, Jinenez JJ, et al (2003) Effects of severe hypertension on endothelial and platelet microparticles. Hypertension 41:211–7
Kaplan NM (2005) Systemic hypertension: therapy. In: Zipes DP, Libby P, Bonow RO, Braunwald E (eds) Braunwald’s heart disease, 7th edn. Elsevier Saunders, Philadelphia, pp 989–1010
Lee TH (2005) Systemic hypertension: guidelines. In: Zipes DP, Libby P, Bonow RO, Braunwald E (eds) Braunwald’s heart disease, 7th edn. Elsevier Saunders, Philadelphia, pp 1010–12
Moss J, Glick D (2005) The autonomic nervous system. In: Miller RD (ed) Miller’s anesthesia, 6th edn. Elsevier Churchill Livingstone, Philadelphia, pp 617–77
Hoffman B (2001) Catecholamines, sympathomimetc drugs, and adrenergic receptor antagonists. In: Hardman JG, Limbird LE (eds) Goodman & Gilman’s The pharmacological basis of therapeutics, 10th edn. McGraw-Hill, New York, pp 215–68
Saunders-Bush E, Mayer SE (2001) 5-Hydroxytryptamine (serotonin): receptor agonists and antagonists. In: Hardman JG, Limbird LE (eds) Goodman & Gilman’s The pharmacological basis of therapeutics, 10th edn. McGraw-Hill, New York, pp 269–90
Jackson (2001) Diuretics. In, Hardman JG, Limbird LE (2001) Goodman & Gilman’s The Pharmacological Basis of Therapeutics, 10th edition. New York, McGraw-Hill, pp 757–87
Kerins DM, Robertson RM, Robertson D (2001) Drugs used for treatment of myocardial ischemia. In: Hardman JG, Limbird LE (eds) Goodman & Gilman’s The pharmacological basis of therapeutics, 10th edn. McGraw-Hill, New York, pp 843–70
Oates LA, Brown NJ (2001) Antihypertensive agents and the drug therapy of hypertension. In: Hardman JG, Limbird LE (eds) Goodman & Gilman’s The pharmacological basis of therapeutics, 10th edn. McGraw-Hill, New York, pp 871–900
Stone GW, McCullough PA, Tumlin JA, et al (2003) Fenoldopam mesylate for the prevention of contrast-induced nephropathy: a randomized controlled trial. JAMA 290:2284–91
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2007 Springer-Verlag Italia
About this chapter
Cite this chapter
Atlee, J.L. (2007). Hypertensive Urgencies and Emergencies. In: Perioperative Critical Care Cardiology. Topics in Anaesthesia and Critical Care. Springer, Milano. https://doi.org/10.1007/978-88-470-0558-7_4
Download citation
DOI: https://doi.org/10.1007/978-88-470-0558-7_4
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-0557-0
Online ISBN: 978-88-470-0558-7
eBook Packages: MedicineMedicine (R0)